1. Home
  2. BHVN vs WLDN Comparison

BHVN vs WLDN Comparison

Compare BHVN & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • WLDN
  • Stock Information
  • Founded
  • BHVN 2013
  • WLDN 1964
  • Country
  • BHVN United States
  • WLDN United States
  • Employees
  • BHVN N/A
  • WLDN N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • WLDN Military/Government/Technical
  • Sector
  • BHVN Health Care
  • WLDN Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • WLDN Nasdaq
  • Market Cap
  • BHVN 1.9B
  • WLDN 1.6B
  • IPO Year
  • BHVN 2017
  • WLDN 2006
  • Fundamental
  • Price
  • BHVN $16.52
  • WLDN $102.24
  • Analyst Decision
  • BHVN Strong Buy
  • WLDN Strong Buy
  • Analyst Count
  • BHVN 14
  • WLDN 3
  • Target Price
  • BHVN $49.23
  • WLDN $114.33
  • AVG Volume (30 Days)
  • BHVN 2.1M
  • WLDN 247.5K
  • Earning Date
  • BHVN 11-11-2025
  • WLDN 11-06-2025
  • Dividend Yield
  • BHVN N/A
  • WLDN N/A
  • EPS Growth
  • BHVN N/A
  • WLDN 94.22
  • EPS
  • BHVN N/A
  • WLDN 2.39
  • Revenue
  • BHVN N/A
  • WLDN $628,172,000.00
  • Revenue This Year
  • BHVN N/A
  • WLDN N/A
  • Revenue Next Year
  • BHVN $2,079.03
  • WLDN $9.00
  • P/E Ratio
  • BHVN N/A
  • WLDN $42.75
  • Revenue Growth
  • BHVN N/A
  • WLDN 13.82
  • 52 Week Low
  • BHVN $12.79
  • WLDN $30.43
  • 52 Week High
  • BHVN $54.98
  • WLDN $121.00
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 54.24
  • WLDN 58.53
  • Support Level
  • BHVN $16.30
  • WLDN $90.93
  • Resistance Level
  • BHVN $18.18
  • WLDN $99.34
  • Average True Range (ATR)
  • BHVN 1.26
  • WLDN 4.46
  • MACD
  • BHVN 0.02
  • WLDN 0.96
  • Stochastic Oscillator
  • BHVN 55.52
  • WLDN 92.77

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

Share on Social Networks: